Loading…
Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings
To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings. Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers...
Saved in:
Published in: | Investigative ophthalmology & visual science 2019-11, Vol.60 (14), p.4691-4700 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223 |
---|---|
cites | cdi_FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223 |
container_end_page | 4700 |
container_issue | 14 |
container_start_page | 4691 |
container_title | Investigative ophthalmology & visual science |
container_volume | 60 |
creator | Nakamura, Natsuko Tsunoda, Kazushige Mizuno, Yoshinobu Usui, Tomoaki Hatase, Tetsuhisa Ueno, Shinji Kuniyoshi, Kazuki Hayashi, Takaaki Katagiri, Satoshi Kondo, Mineo Kameya, Shuhei Yoshitake, Kazutoshi Fujinami, Kaoru Iwata, Takeshi Miyake, Yozo |
description | To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings.
Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers in Japan. Ophthalmological examinations including the best-corrected visual acuity (BVCA) and OCT were performed.
The median age at the last visit was 50 years with a range of 10 to 88 years, and the median age at the symptom onset was 30 years with a range of 3 to 60 years. There were significant negative correlations between the duration of OMD and BCVA, the central retinal thickness (CRT) and the thickness between external limiting membrane and retinal pigment epithelium (ERT). The BCVA gradually decreased for 10 years after symptom onset and was stable thereafter. Kaplan-Meier survival curves of the BCVA and retinal thickness showed that all of the patients had retained a vision of 1.0 logMAR, and over 80% of the patients had retained 50% thickness of the normal CRT and ERT for at least 60 years after symptom onset. The stages of OMD based on the visual symptoms and OCT findings are proposed.
The photoreceptors do not become completely atrophic even at the late stage, which may account for the good retinal pigment epithelium (RPE) structure and normal-appearing fundus. The proposed stages facilitate the investigation of the pathogenicity of OMD and provide information to determine the effectiveness of therapeutic procedures. |
doi_str_mv | 10.1167/iovs.19-27486 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2314574287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2314574287</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223</originalsourceid><addsrcrecordid>eNpNkDFPwzAUhC0EoqUwsiKPLCl-dmInIwQKSEUdKBND5DgvbVASBztB6r-nLQUx3Q3f3fARcglsCiDVTWW__BSSgKswlkdkDFHEg0jF4vhfH5Ez7z8Y4wCcnZKRAMUjkPGYvKd11VZG1_S11yv01JZ0YcxQ9_RFb0M7er_xvbPdekPvtMeC2pYuun6_Se0aHbYG6dI2duV0t64MnVVtUbUrf05OSl17vDjkhLzNHpbpUzBfPD6nt_PAiCTuAy55wUJI8pDFORqFXItIhzkYHsoSCxOWpsRY5kYYyRAAchScYcyUlMC5mJDrn9_O2c8BfZ81lTdY17pFO_iMCwgjFfJYbdHgBzXOeu-wzDpXNdptMmDZzme285lBku19bvmrw_WQN1j80b8CxTeqlXGh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2314574287</pqid></control><display><type>article</type><title>Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings</title><source>PubMed Central</source><creator>Nakamura, Natsuko ; Tsunoda, Kazushige ; Mizuno, Yoshinobu ; Usui, Tomoaki ; Hatase, Tetsuhisa ; Ueno, Shinji ; Kuniyoshi, Kazuki ; Hayashi, Takaaki ; Katagiri, Satoshi ; Kondo, Mineo ; Kameya, Shuhei ; Yoshitake, Kazutoshi ; Fujinami, Kaoru ; Iwata, Takeshi ; Miyake, Yozo</creator><creatorcontrib>Nakamura, Natsuko ; Tsunoda, Kazushige ; Mizuno, Yoshinobu ; Usui, Tomoaki ; Hatase, Tetsuhisa ; Ueno, Shinji ; Kuniyoshi, Kazuki ; Hayashi, Takaaki ; Katagiri, Satoshi ; Kondo, Mineo ; Kameya, Shuhei ; Yoshitake, Kazutoshi ; Fujinami, Kaoru ; Iwata, Takeshi ; Miyake, Yozo</creatorcontrib><description>To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings.
Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers in Japan. Ophthalmological examinations including the best-corrected visual acuity (BVCA) and OCT were performed.
The median age at the last visit was 50 years with a range of 10 to 88 years, and the median age at the symptom onset was 30 years with a range of 3 to 60 years. There were significant negative correlations between the duration of OMD and BCVA, the central retinal thickness (CRT) and the thickness between external limiting membrane and retinal pigment epithelium (ERT). The BCVA gradually decreased for 10 years after symptom onset and was stable thereafter. Kaplan-Meier survival curves of the BCVA and retinal thickness showed that all of the patients had retained a vision of 1.0 logMAR, and over 80% of the patients had retained 50% thickness of the normal CRT and ERT for at least 60 years after symptom onset. The stages of OMD based on the visual symptoms and OCT findings are proposed.
The photoreceptors do not become completely atrophic even at the late stage, which may account for the good retinal pigment epithelium (RPE) structure and normal-appearing fundus. The proposed stages facilitate the investigation of the pathogenicity of OMD and provide information to determine the effectiveness of therapeutic procedures.</description><identifier>ISSN: 1552-5783</identifier><identifier>EISSN: 1552-5783</identifier><identifier>DOI: 10.1167/iovs.19-27486</identifier><identifier>PMID: 31725168</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Disease Progression ; Eye Proteins - genetics ; Female ; Fluorescein Angiography ; Humans ; Macular Degeneration - diagnosis ; Macular Degeneration - genetics ; Macular Degeneration - physiopathology ; Male ; Middle Aged ; Photoreceptor Cells, Vertebrate - physiology ; Retina - diagnostic imaging ; Retina - physiopathology ; Retinal Pigment Epithelium - physiology ; Tomography, Optical Coherence ; Visual Acuity - physiology</subject><ispartof>Investigative ophthalmology & visual science, 2019-11, Vol.60 (14), p.4691-4700</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223</citedby><cites>FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31725168$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakamura, Natsuko</creatorcontrib><creatorcontrib>Tsunoda, Kazushige</creatorcontrib><creatorcontrib>Mizuno, Yoshinobu</creatorcontrib><creatorcontrib>Usui, Tomoaki</creatorcontrib><creatorcontrib>Hatase, Tetsuhisa</creatorcontrib><creatorcontrib>Ueno, Shinji</creatorcontrib><creatorcontrib>Kuniyoshi, Kazuki</creatorcontrib><creatorcontrib>Hayashi, Takaaki</creatorcontrib><creatorcontrib>Katagiri, Satoshi</creatorcontrib><creatorcontrib>Kondo, Mineo</creatorcontrib><creatorcontrib>Kameya, Shuhei</creatorcontrib><creatorcontrib>Yoshitake, Kazutoshi</creatorcontrib><creatorcontrib>Fujinami, Kaoru</creatorcontrib><creatorcontrib>Iwata, Takeshi</creatorcontrib><creatorcontrib>Miyake, Yozo</creatorcontrib><title>Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings</title><title>Investigative ophthalmology & visual science</title><addtitle>Invest Ophthalmol Vis Sci</addtitle><description>To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings.
Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers in Japan. Ophthalmological examinations including the best-corrected visual acuity (BVCA) and OCT were performed.
The median age at the last visit was 50 years with a range of 10 to 88 years, and the median age at the symptom onset was 30 years with a range of 3 to 60 years. There were significant negative correlations between the duration of OMD and BCVA, the central retinal thickness (CRT) and the thickness between external limiting membrane and retinal pigment epithelium (ERT). The BCVA gradually decreased for 10 years after symptom onset and was stable thereafter. Kaplan-Meier survival curves of the BCVA and retinal thickness showed that all of the patients had retained a vision of 1.0 logMAR, and over 80% of the patients had retained 50% thickness of the normal CRT and ERT for at least 60 years after symptom onset. The stages of OMD based on the visual symptoms and OCT findings are proposed.
The photoreceptors do not become completely atrophic even at the late stage, which may account for the good retinal pigment epithelium (RPE) structure and normal-appearing fundus. The proposed stages facilitate the investigation of the pathogenicity of OMD and provide information to determine the effectiveness of therapeutic procedures.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Child</subject><subject>Disease Progression</subject><subject>Eye Proteins - genetics</subject><subject>Female</subject><subject>Fluorescein Angiography</subject><subject>Humans</subject><subject>Macular Degeneration - diagnosis</subject><subject>Macular Degeneration - genetics</subject><subject>Macular Degeneration - physiopathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Photoreceptor Cells, Vertebrate - physiology</subject><subject>Retina - diagnostic imaging</subject><subject>Retina - physiopathology</subject><subject>Retinal Pigment Epithelium - physiology</subject><subject>Tomography, Optical Coherence</subject><subject>Visual Acuity - physiology</subject><issn>1552-5783</issn><issn>1552-5783</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpNkDFPwzAUhC0EoqUwsiKPLCl-dmInIwQKSEUdKBND5DgvbVASBztB6r-nLQUx3Q3f3fARcglsCiDVTWW__BSSgKswlkdkDFHEg0jF4vhfH5Ez7z8Y4wCcnZKRAMUjkPGYvKd11VZG1_S11yv01JZ0YcxQ9_RFb0M7er_xvbPdekPvtMeC2pYuun6_Se0aHbYG6dI2duV0t64MnVVtUbUrf05OSl17vDjkhLzNHpbpUzBfPD6nt_PAiCTuAy55wUJI8pDFORqFXItIhzkYHsoSCxOWpsRY5kYYyRAAchScYcyUlMC5mJDrn9_O2c8BfZ81lTdY17pFO_iMCwgjFfJYbdHgBzXOeu-wzDpXNdptMmDZzme285lBku19bvmrw_WQN1j80b8CxTeqlXGh</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Nakamura, Natsuko</creator><creator>Tsunoda, Kazushige</creator><creator>Mizuno, Yoshinobu</creator><creator>Usui, Tomoaki</creator><creator>Hatase, Tetsuhisa</creator><creator>Ueno, Shinji</creator><creator>Kuniyoshi, Kazuki</creator><creator>Hayashi, Takaaki</creator><creator>Katagiri, Satoshi</creator><creator>Kondo, Mineo</creator><creator>Kameya, Shuhei</creator><creator>Yoshitake, Kazutoshi</creator><creator>Fujinami, Kaoru</creator><creator>Iwata, Takeshi</creator><creator>Miyake, Yozo</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20191101</creationdate><title>Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings</title><author>Nakamura, Natsuko ; Tsunoda, Kazushige ; Mizuno, Yoshinobu ; Usui, Tomoaki ; Hatase, Tetsuhisa ; Ueno, Shinji ; Kuniyoshi, Kazuki ; Hayashi, Takaaki ; Katagiri, Satoshi ; Kondo, Mineo ; Kameya, Shuhei ; Yoshitake, Kazutoshi ; Fujinami, Kaoru ; Iwata, Takeshi ; Miyake, Yozo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Child</topic><topic>Disease Progression</topic><topic>Eye Proteins - genetics</topic><topic>Female</topic><topic>Fluorescein Angiography</topic><topic>Humans</topic><topic>Macular Degeneration - diagnosis</topic><topic>Macular Degeneration - genetics</topic><topic>Macular Degeneration - physiopathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Photoreceptor Cells, Vertebrate - physiology</topic><topic>Retina - diagnostic imaging</topic><topic>Retina - physiopathology</topic><topic>Retinal Pigment Epithelium - physiology</topic><topic>Tomography, Optical Coherence</topic><topic>Visual Acuity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakamura, Natsuko</creatorcontrib><creatorcontrib>Tsunoda, Kazushige</creatorcontrib><creatorcontrib>Mizuno, Yoshinobu</creatorcontrib><creatorcontrib>Usui, Tomoaki</creatorcontrib><creatorcontrib>Hatase, Tetsuhisa</creatorcontrib><creatorcontrib>Ueno, Shinji</creatorcontrib><creatorcontrib>Kuniyoshi, Kazuki</creatorcontrib><creatorcontrib>Hayashi, Takaaki</creatorcontrib><creatorcontrib>Katagiri, Satoshi</creatorcontrib><creatorcontrib>Kondo, Mineo</creatorcontrib><creatorcontrib>Kameya, Shuhei</creatorcontrib><creatorcontrib>Yoshitake, Kazutoshi</creatorcontrib><creatorcontrib>Fujinami, Kaoru</creatorcontrib><creatorcontrib>Iwata, Takeshi</creatorcontrib><creatorcontrib>Miyake, Yozo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Investigative ophthalmology & visual science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakamura, Natsuko</au><au>Tsunoda, Kazushige</au><au>Mizuno, Yoshinobu</au><au>Usui, Tomoaki</au><au>Hatase, Tetsuhisa</au><au>Ueno, Shinji</au><au>Kuniyoshi, Kazuki</au><au>Hayashi, Takaaki</au><au>Katagiri, Satoshi</au><au>Kondo, Mineo</au><au>Kameya, Shuhei</au><au>Yoshitake, Kazutoshi</au><au>Fujinami, Kaoru</au><au>Iwata, Takeshi</au><au>Miyake, Yozo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings</atitle><jtitle>Investigative ophthalmology & visual science</jtitle><addtitle>Invest Ophthalmol Vis Sci</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>60</volume><issue>14</issue><spage>4691</spage><epage>4700</epage><pages>4691-4700</pages><issn>1552-5783</issn><eissn>1552-5783</eissn><abstract>To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings.
Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers in Japan. Ophthalmological examinations including the best-corrected visual acuity (BVCA) and OCT were performed.
The median age at the last visit was 50 years with a range of 10 to 88 years, and the median age at the symptom onset was 30 years with a range of 3 to 60 years. There were significant negative correlations between the duration of OMD and BCVA, the central retinal thickness (CRT) and the thickness between external limiting membrane and retinal pigment epithelium (ERT). The BCVA gradually decreased for 10 years after symptom onset and was stable thereafter. Kaplan-Meier survival curves of the BCVA and retinal thickness showed that all of the patients had retained a vision of 1.0 logMAR, and over 80% of the patients had retained 50% thickness of the normal CRT and ERT for at least 60 years after symptom onset. The stages of OMD based on the visual symptoms and OCT findings are proposed.
The photoreceptors do not become completely atrophic even at the late stage, which may account for the good retinal pigment epithelium (RPE) structure and normal-appearing fundus. The proposed stages facilitate the investigation of the pathogenicity of OMD and provide information to determine the effectiveness of therapeutic procedures.</abstract><cop>United States</cop><pmid>31725168</pmid><doi>10.1167/iovs.19-27486</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-5783 |
ispartof | Investigative ophthalmology & visual science, 2019-11, Vol.60 (14), p.4691-4700 |
issn | 1552-5783 1552-5783 |
language | eng |
recordid | cdi_proquest_miscellaneous_2314574287 |
source | PubMed Central |
subjects | Adolescent Adult Aged Aged, 80 and over Child Disease Progression Eye Proteins - genetics Female Fluorescein Angiography Humans Macular Degeneration - diagnosis Macular Degeneration - genetics Macular Degeneration - physiopathology Male Middle Aged Photoreceptor Cells, Vertebrate - physiology Retina - diagnostic imaging Retina - physiopathology Retinal Pigment Epithelium - physiology Tomography, Optical Coherence Visual Acuity - physiology |
title | Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A23%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Stages%20of%20Occult%20Macular%20Dystrophy%20Based%20on%20Optical%20Coherence%20Tomographic%20Findings&rft.jtitle=Investigative%20ophthalmology%20&%20visual%20science&rft.au=Nakamura,%20Natsuko&rft.date=2019-11-01&rft.volume=60&rft.issue=14&rft.spage=4691&rft.epage=4700&rft.pages=4691-4700&rft.issn=1552-5783&rft.eissn=1552-5783&rft_id=info:doi/10.1167/iovs.19-27486&rft_dat=%3Cproquest_cross%3E2314574287%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2314574287&rft_id=info:pmid/31725168&rfr_iscdi=true |